Endometrial expression of anti-müllerian hormone and its receptor type II in women with polycystic ovary syndrome
ConclusionsAlthough PCOS is associated with increased serum levels of AMH, protein expression of AMH and its receptor in the endometrium was not different to controls, and moreover not affected by lifestyle modification. Endometrial AMH-R immunostaining increased significantly during the menstrual cycle in both women with PCOS and controls. Our results imply that circulating AMH is not affecting expression of AMH and its receptor in the endometrium.The clinical trial registry numberID ISRCTN18400086.
Source: Reproductive BioMedicine Online - Category: Reproduction Medicine Source Type: research
More News: Clinical Trials | Eating Disorders & Weight Management | Hormones | Men | Obesity | Ovaries | Polycystic Ovary Syndrome | Reproduction Medicine | Women